221 related articles for article (PubMed ID: 27384589)
1. Turning on the Radio: Epigenetic Inhibitors as Potential Radiopriming Agents.
Oronsky B; Scicinski J; Kim MM; Cabrales P; Salacz ME; Carter CA; Oronsky N; Lybeck H; Lybeck M; Larson C; Reid TR; Oronsky A
Biomolecules; 2016 Jul; 6(3):. PubMed ID: 27384589
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic mechanisms underlying prostate cancer radioresistance.
Macedo-Silva C; Benedetti R; Ciardiello F; Cappabianca S; Jerónimo C; Altucci L
Clin Epigenetics; 2021 Jun; 13(1):125. PubMed ID: 34103085
[TBL] [Abstract][Full Text] [Related]
3. The pivotal role of DNA methylation in the radio-sensitivity of tumor radiotherapy.
Zhu X; Wang Y; Tan L; Fu X
Cancer Med; 2018 Aug; 7(8):3812-3819. PubMed ID: 29952116
[TBL] [Abstract][Full Text] [Related]
4. Unraveling Mitochondrial Determinants of Tumor Response to Radiation Therapy.
Zaffaroni M; Vincini MG; Corrao G; Marvaso G; Pepa M; Viglietto G; Amodio N; Jereczek-Fossa BA
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232638
[TBL] [Abstract][Full Text] [Related]
5. Nrf2 is a potential therapeutic target in radioresistance in human cancer.
Zhou S; Ye W; Shao Q; Zhang M; Liang J
Crit Rev Oncol Hematol; 2013 Dec; 88(3):706-15. PubMed ID: 24126138
[TBL] [Abstract][Full Text] [Related]
6. DNA methylome analysis identifies epigenetic silencing of FHIT as a determining factor for radiosensitivity in oral cancer: an outcome-predicting and treatment-implicating study.
Lin HY; Hung SK; Lee MS; Chiou WY; Huang TT; Tseng CE; Shih LY; Lin RI; Lin JM; Lai YH; Chang CB; Hsu FC; Chen LC; Tsai SJ; Su YC; Li SC; Lai HC; Hsu WL; Liu DW; Tai CK; Wu SF; Chan MW
Oncotarget; 2015 Jan; 6(2):915-34. PubMed ID: 25460508
[TBL] [Abstract][Full Text] [Related]
7. Impact of DNA and RNA Methylation on Radiobiology and Cancer Progression.
Chi HC; Tsai CY; Tsai MM; Lin KH
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29439529
[TBL] [Abstract][Full Text] [Related]
8. Deciphering the epigenetic network in cancer radioresistance.
Cabrera-Licona A; Pérez-Añorve IX; Flores-Fortis M; Moral-Hernández OD; González-de la Rosa CH; Suárez-Sánchez R; Chávez-Saldaña M; Aréchaga-Ocampo E
Radiother Oncol; 2021 Jun; 159():48-59. PubMed ID: 33741468
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic therapy for solid tumors: from bench science to clinical trials.
Juo YY; Gong XJ; Mishra A; Cui X; Baylin SB; Azad NS; Ahuja N
Epigenomics; 2015; 7(2):215-35. PubMed ID: 25942532
[TBL] [Abstract][Full Text] [Related]
10. Epigenetics as a determinant of radiation response in cancer.
Arechaga-Ocampo E
Int Rev Cell Mol Biol; 2024; 383():145-190. PubMed ID: 38359968
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic therapy and chemosensitization in solid malignancy.
Ronnekleiv-Kelly SM; Sharma A; Ahuja N
Cancer Treat Rev; 2017 Apr; 55():200-208. PubMed ID: 28431263
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic regulation and cancer (review).
Chen QW; Zhu XY; Li YY; Meng ZQ
Oncol Rep; 2014 Feb; 31(2):523-32. PubMed ID: 24337819
[TBL] [Abstract][Full Text] [Related]
13. Radiosensitization by targeting radioresistance-related genes with protein kinase A inhibitor in radioresistant cancer cells.
Chin C; Bae JH; Kim MJ; Hwang JY; Kim SJ; Yoon MS; Lee MK; Kim DW; Chung BS; Kang CD; Kim SH
Exp Mol Med; 2005 Dec; 37(6):608-18. PubMed ID: 16391522
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic modulation with histone deacetylase inhibitors in combination with immunotherapy.
Park J; Thomas S; Munster PN
Epigenomics; 2015; 7(4):641-52. PubMed ID: 26111034
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic inhibitors.
Verma M; Banerjee HN
Methods Mol Biol; 2015; 1238():469-85. PubMed ID: 25421675
[TBL] [Abstract][Full Text] [Related]
16. The expanding role of epigenetics in the development, diagnosis and treatment of prostate cancer and benign prostatic hyperplasia.
Dobosy JR; Roberts JL; Fu VX; Jarrard DF
J Urol; 2007 Mar; 177(3):822-31. PubMed ID: 17296351
[TBL] [Abstract][Full Text] [Related]
17. [Epigenetics and cancer].
Xue C; Yu J; Liu H; Chen J
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2009 Oct; 26(5):1133-6. PubMed ID: 19947505
[TBL] [Abstract][Full Text] [Related]
18. Epigenetics in cancer: what's the future?
Boumber Y; Issa JP
Oncology (Williston Park); 2011 Mar; 25(3):220-6, 228. PubMed ID: 21548464
[TBL] [Abstract][Full Text] [Related]
19. Knockdown of microRNA-1323 restores sensitivity to radiation by suppression of PRKDC activity in radiation-resistant lung cancer cells.
Li Y; Han W; Ni TT; Lu L; Huang M; Zhang Y; Cao H; Zhang HQ; Luo W; Li H
Oncol Rep; 2015 Jun; 33(6):2821-8. PubMed ID: 25823795
[TBL] [Abstract][Full Text] [Related]
20. An Epigenetic Reprogramming Strategy to Resensitize Radioresistant Prostate Cancer Cells.
Peitzsch C; Cojoc M; Hein L; Kurth I; Mäbert K; Trautmann F; Klink B; Schröck E; Wirth MP; Krause M; Stakhovsky EA; Telegeev GD; Novotny V; Toma M; Muders M; Baretton GB; Frame FM; Maitland NJ; Baumann M; Dubrovska A
Cancer Res; 2016 May; 76(9):2637-51. PubMed ID: 26984757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
